Mitraz tablet all uses
Reading File
Searching the Web
Mitraz mirtazapine tablet uses indications
Finding Sources
Reading Web Page
mirtazapine uses indications
Here is a complete overview of Mitraz (Mirtazapine) tablet - all uses:
Mitraz (Mirtazapine) - Complete Uses
Drug Overview
Mitraz contains mirtazapine, a noradrenergic and specific serotonergic antidepressant (NaSSA). It works by blocking alpha-2 adrenergic receptors (increasing noradrenaline and serotonin release) and blocking specific serotonin receptors (5-HT2, 5-HT3) and histamine (H1) receptors.
FDA-Approved / Primary Use
| Use | Details |
|---|---|
| Major Depressive Disorder (MDD) | First-line antidepressant at 15-45 mg/day. Works faster than SSRIs - improvement seen within 1-2 weeks. Especially effective in anxious depression and melancholic depression. |
Off-Label / Established Clinical Uses
Psychiatric:
- Generalized Anxiety Disorder (GAD) - due to anxiolytic properties
- Post-Traumatic Stress Disorder (PTSD) - reduces nightmares and hyperarousal
- Panic Disorder - adjunct or monotherapy
- OCD (Obsessive Compulsive Disorder) - sometimes used as adjunct
- Treatment-Resistant Depression - combined with SSRIs/SNRIs (called "California Rocket Fuel" when combined with venlafaxine)
- Geriatric Depression - well-tolerated in elderly, especially agitated elderly patients
- Depression with alcohol dependence - evidence for efficacy in this subgroup
Sleep:
- Insomnia - at low doses (7.5-15 mg), strong sedative effect via H1 blockade; paradoxically, higher doses are less sedating
Appetite and Weight:
- Appetite stimulation - used in cancer cachexia, HIV wasting syndrome, cystic fibrosis-related weight loss, and anorexia nervosa (adjunct)
- Cancer-related weight loss - evidence for use to promote weight gain
Gastrointestinal:
- Nausea and vomiting (antiemetic) - via 5-HT3 receptor blockade; used in chemotherapy-related nausea, and notably in hyperemesis gravidarum when standard antiemetics fail
Pain:
- Chronic pain / neuropathic pain - emerging evidence for analgesic benefits
- Headache / migraine prophylaxis - used as preventive agent
Other Medical Conditions:
- Post-stroke depression - safe and effective
- Post-myocardial infarction depression - considered safer than TCAs in cardiac patients
- Depression with temporal lobe epilepsy - some evidence of safety and efficacy
Key Pharmacological Properties Behind These Uses
| Property | Receptor | Clinical Benefit |
|---|---|---|
| Increases noradrenaline & serotonin | Alpha-2 blockade | Antidepressant, anxiolytic |
| Sedation | H1 (histamine) blockade | Insomnia, agitation |
| Antiemetic | 5-HT3 blockade | Nausea, vomiting |
| Appetite stimulation | H1 blockade + other | Weight gain, cachexia |
Important Notes
- Dose-dependent sedation: More sedating at lower doses (15 mg) due to dominant H1 blockade. At higher doses (30-45 mg), noradrenergic effects counteract sedation.
- Not recommended for depression associated with dementia or obstructive sleep apnea (insufficient evidence).
- Available as regular tablets and orally disintegrating tablets (ODT).
Sources: Kaplan & Sadock's Comprehensive Textbook of Psychiatry; Textbook of Family Medicine 9e; PMC Review of Therapeutic Uses of Mirtazapine (PMID: 3907331)
This is a shared conversation. Sign in to Orris to start your own chat.